A non-randomized experimental study will be conducted to investigate the effect of Ecoguided Percutaneous Neuromodulation on patients with and without neck pain in college students. The sample will be collected in a non-probabilistic way at convenience among the students at the San Pablo-CEU University, with a sample that will be divided into two groups: group 1 (G1) with neck pain and group 2 (G2).
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
52
Ecoguided Percutaneous Neuromodulation over the posterior branch of the cervical multifidus, for 10 minutes, with a frequency of 10 HZ.
San Pablo CEU University
Boadilla del Monte, Madrid, Spain
Pain threshold
Portable hand pressure algometer (FPX 50/220, Wagner Instruments, Greenwich, USA), measured in kg / cm² (kilogram per centimeter squared).
Time frame: up to 1 Week
Pain by visual analog scale
usual visual analog scale (VAS) of pain (line from 0: no pain to 10:worst pain)
Time frame: Baseline
Pain by visual analog scale
usual visual analog scale (VAS) of pain (line from 0: no pain to 10:worst pain)
Time frame: after intervention
Pain by visual analog scale
usual visual analog scale (VAS) of pain (line from 0: no pain to 10:worst pain)
Time frame: Follow-up at 1 week
Neck Disability Index Questionnaire.
Quantification of pain and disabilty
Time frame: Baseline
Neck Disability Index Questionnaire.
Quantification of pain and disabilty
Time frame: after intervention
Neck Disability Index Questionnaire.
Quantification of pain and disabilty
Time frame: Follow-up at 1 week
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Baseline
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Time frame: after intervention
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Time frame: Follow-up at 1 week
Pain Catastrophizing Scale
Pain Catastrophizing Scale (PAS) will be used to evaluate the participants' pain-related thoughts and feelings.
Time frame: Baseline
Pain Catastrophizing Scale
Pain Catastrophizing Scale (PAS) will be used to evaluate the participants' pain-related thoughts and feelings.
Time frame: after intervention
Pain Catastrophizing Scale
Pain Catastrophizing Scale (PAS) will be used to evaluate the participants' pain-related thoughts and feelings.
Time frame: Follow-up at 1 week
Health-related quality of life
The Short Form Health Questionnaire (SF-36) questionnaire, which examines health-related quality of life under eight sub-titles; It consists of 36 items. The SF36 questionnaire will be used in the study.
Time frame: Baseline
Health-related quality of life
The Short Form Health Questionnaire (SF-36) questionnaire, which examines health-related quality of life under eight sub-titles; It consists of 36 items. The SF36 questionnaire will be used in the study.
Time frame: after intervention
Health-related quality of life
The Short Form Health Questionnaire (SF-36) questionnaire, which examines health-related quality of life under eight sub-titles; It consists of 36 items. The SF36 questionnaire will be used in the study.
Time frame: Follow-up at 1 week
Sonoelastography
This diagnostic test would be executed by a Physiotherapist who has experiences of using General Electric, P9 model ultrasound system for more than three year. The equipment to obtain the image will be used with a frequency of 12 MHz, 22 dB gain, 85 dynamic range, brightness at 17 and depth of 4 cm. The transducer will be placed on the spinosa of C4 and the probe will be moved towards the transverse of each of the sides, to identify the image of the multifidus muscle in depth. Once the muscle is located in this segment, a longitudinal and transverse image of the muscle will be obtained, performing the elastography at the same time and calculating the elastographic values (tissue resistance in kilopascals and transmission speed in meters/second).
Time frame: Baseline
Sonoelastography
This diagnostic test would be executed by a Physiotherapist who has experiences of using General Electric, P9 model ultrasound system for more than three year. The equipment to obtain the image will be used with a frequency of 12 MHz, 22 dB gain, 85 dynamic range, brightness at 17 and depth of 4 cm. The transducer will be placed on the spinosa of C4 and the probe will be moved towards the transverse of each of the sides, to identify the image of the multifidus muscle in depth. Once the muscle is located in this segment, a longitudinal and transverse image of the muscle will be obtained, performing the elastography at the same time and calculating the elastographic values (tissue resistance in kilopascals and transmission speed in meters/second).
Time frame: after intervention
Sonoelastography
This diagnostic test would be executed by a Physiotherapist who has experiences of using General Electric, P9 model ultrasound system for more than three year. The equipment to obtain the image will be used with a frequency of 12 MHz, 22 dB gain, 85 dynamic range, brightness at 17 and depth of 4 cm. The transducer will be placed on the spinosa of C4 and the probe will be moved towards the transverse of each of the sides, to identify the image of the multifidus muscle in depth. Once the muscle is located in this segment, a longitudinal and transverse image of the muscle will be obtained, performing the elastography at the same time and calculating the elastographic values (tissue resistance in kilopascals and transmission speed in meters/second).
Time frame: Follow-up at 1 week